ChristopherETouloukianMD
General Surgery • Indianapolis, INAssociate Professor, Surgery, Indiana University School of Medicine
Are you Dr. Touloukian?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 110 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
545 Barnhill Dr Eh 5th Floor
University Surgeons Inc
Indianapolis, IN 46202Phone+1 317-274-4122Fax+1 317-274-0241- Is this information wrong?
Summary
- Dr. Christopher Touloukian, MD is a general surgeon in Indianapolis, Indiana. He is currently licensed to practice medicine in Indiana, Massachusetts, and Connecticut. He is affiliated with NYC Health + Hospitals / Queens and is an Associate Professor at Indiana University School of Medicine.
Education & Training
Duke University HospitalResidency, Surgery, 2001 - 2004
Yale-New Haven Medical CenterResidency, Surgery, 1994 - 2000
Columbia University Vagelos College of Physicians and SurgeonsClass of 1994
Certifications & Licensure
MA State Medical License 2017 - 2025
NY State Medical License 2014 - 2024
CT State Medical License 2016 - 2017
IN State Medical License 2004 - 2017
NC State Medical License 2001 - 2004- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 34 citationsChemotherapeutic Agents Subvert Tumor Immunity by Generating Agonists of Platelet-Activating FactorRavi P. Sahu, Jesus A. Ocana, Kathleen A. Harrison, Matheus Ferracini, Christopher E. Touloukian, Mohammed Al-Hassani, Louis Sun, Mathew M. Loesch, Robert C. Murphy, S...> ;Cancer Research. 2014 Dec 1
- 6 citationsImpaired PIASy-Tip60 signaling weakens activation of p53 in melanoma.Alexander J. Lakhter, Sriramana Kanginakudru, Simon Warren, Christopher E. Touloukian, Raymond E. Boissy, Samisubbu R. Naidu> ;Melanoma Research. 2013 Jun 1
- 50 citationsThe environmental stressor ultraviolet B radiation inhibits murine antitumor immunity through its ability to generate platelet-activating factor agonistsRavi P. Sahu, Matthew J. Turner, Sonia C. DaSilva, Badri Rashid, Jesus A. Ocana, Susan M. Perkins, Raymond L. Konger, Christopher E. Touloukian, Mark H. Kaplan, Jeffre...> ;Carcinogenesis. 2012 Jul 1
- Join now to see all
Press Mentions
New Doctor Joins Expanded Berkshire Surgical Services of BMCJune 5th, 2017
Grant Support
- Durable CD4+ T-Cell Tumor Immunity Following Gene-Modified HpscNational Cancer Institute2009–2012
Professional Memberships
- Member
Hospital Affiliations
NYC Health + Hospitals / QueensJamaica, New York
